SN Share Price

Open 1207.00 Change Price %
High 1211.78 1 Day -4.00 -0.33
Low 1201.00 1 Week 17.00 1.43
Close 1203.00 1 Month -16.00 -1.31
Volume 3284228 1 Year 54.00 4.70
52 Week High 1324.00
52 Week Low 1064.91
SN Important Levels
Resistance 2 1212.99
Resistance 1 1208.88
Pivot 1205.26
Support 1 1197.12
Support 2 1193.01
LON UK Most Active Stocks
FRR 0.20 -23.08%
CWC 74.60 0.27%
CWC 74.60 0.27%
CWC 74.60 0.27%
INC 0.04 -20.00%
LLOY 66.86 -0.58%
LGO 0.12 -7.69%
LGO 0.12 -7.69%
LGO 0.12 -7.69%
VOD 198.00 -0.15%
More..
LON UK Top Gainers Stocks
AKT 28.50 5177.78%
HHR 58.00 900.00%
MLD 10.00 700.00%
MES 0.28 75.00%
MES 0.28 75.00%
MES 0.28 75.00%
PFLM 5.75 64.29%
BAF 80.00 63.27%
BAF 80.00 63.27%
BAF 80.00 63.27%
More..
LON UK Top Losers Stocks
ENDV 0.02 -99.85%
KEA 0.10 -91.30%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
DCP 0.50 -75.61%
PCI 3.50 -53.27%
PCI 3.50 -53.27%
BHR 0.02 -33.33%
NBR 0.25 -24.24%
More..

Smith & Nephew PLC (LON: SN)

SN Technical Analysis 3
As on 17th Feb 2017 SN Share Price closed @ 1203.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1196.19 & Buy for SHORT-TERM with Stoploss of 1189.10 we also expect STOCK to react on Following IMPORTANT LEVELS.
SN Target for February
1st Target up-side 1233.15
2nd Target up-side 1264.09
3rd Target up-side 1295.03
1st Target down-side 1144.86
2nd Target down-side 1113.91
3rd Target down-side 1082.97
SN Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.smith-nephew.com
SN Address
SN
15 Adam Street
London, WC2N 6LA
United Kingdom
Phone: 44 20 7401 7646
Fax: 44 20 7930 3353
SN Latest News
How These Medical Equipment Stocks are Faring? -- Smith & Nephew, ABIOMED ...   PR Newswire (press release)   - 17th Feb 17
Smith & Nephew plc (SN) Price Target Cut to GBX 1275   BNB Daily (blog)   - 15th Feb 17
Smith & Nephew plc (SN) PT Lowered to GBX 1350   Sports Perspectives   - 14th Feb 17
Smith & Nephew plc (SN) Receives GBX 1298.25 Average PT from Brokerages   Sports Perspectives   - 12th Feb 17
Smith & Nephew Plc (SNN) Q4 2016 Results - Earnings Call Transcript   Seeking Alpha   - 09th Feb 17
Smith & Nephew profit misses management forecasts   MarketWatch   - 09th Feb 17
ITV Tops European M&A Target List, Ending Smith & Nephew's Reign   Bloomberg   - 01st Feb 17
Berenberg Bank Reaffirms “Hold” Rating for Smith & Nephew plc (SN)   Sports Perspectives   - 23rd Jan 17
Enabling Improved Patient Outcomes with Smith & Nephew's Pioneering Episode of ...   PR Newswire (press release)   - 09th Nov 16
Smith & Nephew Continues To Impress   Seeking Alpha   - 25th Jul 16
Interactive Technical Analysis Chart Smith & Nephew PLC ( SN LON UK )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Smith & Nephew PLC
SN Business Profile
Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The company’s Advanced Surgical Devices segment offers orthopaedic reconstruction implants for hip, knee, and shoulder joints; and ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. It also provides sports medicine products, which offer surgeons an array of instruments, technologies, and implants to perform minimally invasive surgery of the joints, including knee, hip, and shoulder repair; and trauma and extremities products consisting of internal and external devices and other products, including shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures. In addition, this segment provides arthroscopy enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, as well as offers radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissues to healthcare providers. The company’s Advanced Wound Management segment offers a range of initial wound bed preparation and full wound closure products. Its products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers; and products for the treatment of wounds, such as burns and invasive surgery. Smith & Nephew plc primarily serves medical and surgical treatments and service providers. The company was founded in 1856 and is headquartered in London, the United Kingdom.